Bicara Therapeutics Inc. (BCAX)

Last Closing Price: 24.01 (2026-04-17)

Gross Margin (Quarterly)

Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues

Bicara Therapeutics Inc. (BCAX) Gross Margin data is not available.

Figures for fiscal quarter ending 2025-12-31
Income Statement Financials
--
$-37.39M
--
--
$41.12M
$-41.12M
$3.79M
$-37.33M
$-37.33M
$-37.39M
$-37.39M
$-37.39M
$-37.39M
$-41.12M
$-40.81M
54.68M
54.68M
$-0.67
$-0.67
Balance Sheet Financials
$422.05M
$0.33M
$8.94M
$430.99M
$28.95M
--
$0.59M
$29.54M
$401.45M
$401.45M
$401.45M
56.60M
Cash Flow Statement Financials
$-106.83M
$-318.45M
$32.26M
$489.71M
$96.69M
$-393.03M
$15.01M
--
--
Fundamental Metrics & Ratios
14.58
--
--
--
--
Gross Margin
--
--
--
--
--
--
$-107.11M
--
--
--
--
--
--
--
-9.31%
-9.31%
-8.67%
-9.31%
$7.09
$-1.96
$-1.95